People living with attention deficit hyperactivity disorder (ADHD) have said they are being left feeling “jittery” and “anxious” amidst a global shortage of medicine which they feel is “not being taken seriously”.
The Department for Health and Social Care has said the problem is a result of a worldwide supply issue and increased global demand of ADHD medications including methylphenidate, lisdexamphetamine and guanfacine.
